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THE CHANGE in hepatic pyridine nucleotide levels which results as a consequence of carbon tetra- 
chloride (CCl4) administration has been implicated as a factor in its hepatotoxicity.1-3 Gallagher 
et a1.*-B found that the administration of either nicotinic acid or tryptophan protected rats and sheep 
to a considerable extent against the lethal effects of large doses of CCl4. The injection of nicotinamide 
into normal mice resulted in large increases in the level of nicotinamide adenine dinucleotide (NAD) 
in liver and other tissues.’ It was shown in preliminary studies in our laboratory that, although 
CC14 or nicotinamide (NA) when administered alone to rats did not alter the body temperature, the 
combined effect of these two agents resulted in a fall in temperature from a control level of 368” 
(n = 18) to 33.5” (n = 10). Because it had been shown that the liver damage observed after CC14 
may be prevented, at least in part, by reducing the body temperature,* the protective effects of 
nicotinamide against CC14 were reinvestigated. The data indicate that the protection afforded by 
nicotinamide is not contingent upon a fall in body temperature. 
MATERIALS AND METHODS 
Female albino Sprague-Dawley or Holtzmann rats weighing from 180 to 220 g were used through- 
out the investigation. Animals were sacrihced by decapitation or by exsanguination after excision of 
the liver under light hexobarbital administration. 
A 1 : 1 mixture of CC14 and peanut oil (2.5 ml CC14/kg) was administered orally by stomach tube. 
Control animals were injected with an equal amount of peanut oil. Nicotinamide was administered 
i.p. 23 hr (500 mg/kg), 19 hr (250 mg/kg), and 12 hr (500 mg/kg) before sacrifice. Animals were starved 
20 hr prior to sacrilice. 
The incubator used to maintain the body temperature of the rats consisted of a well ventilated 
oven maintained at 31’. The rectal temperature of the rats was measured with a Tele-thermometer 
(Yellow Springs Instrument Co., Ind.). 
Tissue pyridine nucleotides were measured by selectively destroying the oxidized or reduced 
pyridine nucleotides in base or acid, respectively. Both oxidized and reduced forms of the pyridine 
nucleotides were determined according to the method of Linda11 and Lazarow.9 The pyridine nucleo- 
tide content of mitochondria was measured by the same method after isolation of the mitochondria 
as described by Brody and Bain.10 The protein content of mitochondria was measured by a modifica- 
tion of the method of Gornall et al.ll Statistical comparison was based on the Student’s t-test. Tissues 
for histologic examination were fixed in buffered 10% formalin and hematoxylineosin stained 
sections were prepared. 
RESULTS AND DISCUSSION 
Oxidized and reduced pyridine nucleotides were measured in whole liver and in liver mitochondria 
in six groups of rats: (1) control, (2) CCl4-treated, (3) nicotinamide-treated, (4) nicotinamide-treated 
and incubated, (5) CC14- and nicotinamide-treated, and (6) Ccl*- and nicotinamide-treated and 
incubated. The results of these experiments are shown in Tables 1 and 2. Administration of nicotin- 
amide increased levels of NAD above normal levels. When nicotinamide-treated rats were maintained 
in the incubator, the levels of NAD and total pyridine nucleotides were dramatically decreased below 
that of nonincubated rats treated with nicotinamide. Additionally, when CC14 was given to rats 
that were also given nicotinamide, the NAD fraction was significantly decreased below the levels in 
rats that had received only nicotinamide. This was observed whether the rats were incubated at 31’ or 
left at room temperature. 
Similar changes could also be observed in the levels of reduced pyridine nucleotides. Again, ad- 
ministration of nicotinamide to normal rats significantly elevated NADH levels. Combined CC14 
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and nicotinamide treatment decreased NADH levels below that seen in rats given nicotinamide and 
left at room temperature. 
In experiments with liver mitochondria, the pyridine nucleotide levels were affected in a qualitatively 
similar fashion. The administration of CC14 alone caused a fall in mitochondrial oxidized and reduced 
pyridine nucleotides. Nicotinamide administered concurrently with CC14 maintained the pyridine 
nucleotides at levels above those seen in rats treated with CC14 alone. 
TABLE 1. EFFECT OF CCl4, NICOTINAMIDE AND ENVIRONMENTAL TEMPERATURE ON 
REDUCED AND OXIDIZED PYRIDINE NUCLEOTIDES IN THE LNER* 
N NADH NADPH NAD NADP 
Control 14 129 & 11 214 rt 25 361 + 23 60 9 +z 
cc14 I 56 f 257 89 i 24t 177 f 49t 58 i 12 
NA 7 363 & 14t 301 i_ 42 1420 + 216t 182 * 69 
NA (incubated) 9 225 f 68 277 3: 39 720 k 184: 114 f 50 
CC14 + NA 6 178 t 33: 218 + 27 624 f 63:s 62f31 
CC14 + NA (incubated) 7 160 + 36:§ 233 i 59 589 i 45:s 101 + 34 
* Mean f S.E.M. = pg/g liver, wet weight. 
t Significant difference from control, P < 0.05. 
$ Significant difference from NA alone, P < 0.05. 
5 Signifkzant difference from CC%, P < 0.05. 
TABLE 2. THE EFFECT OF CCl4, NICOTINAMIDE AND ENVIRONMENTAL TEMPERATURE ON 
THE CONTENT OF OXIDIZED AND REDUCED PYRIDINE NUCLEOTIDES IN LIVER MITOCHONDRIA* 
N NADH NADPH NAD NADP 
Control 17 0.95 l 0306 1.74 * 0.13 0.89 * 0.06 0.38 _ir 0.02 
cc14 21 0.59 i 0.06t 0.75 + 0.08t 0.47 & oG4t 0.25 f @04t 
CC14 + NA 12 0.93 * 0.14: 0.99 * 0.14: 0.68 & 0.07t: 0.29 f 0.03t 
CC14 + NA (incubated) 12 0.97 + 0.15: 1.38 * 0.23: 0.67 & 0.07t: 0.30 i 0.067 
* Mean & S.E.M. = pg/mg protein. 
t Significant difference from normal, P < 0.05. 
$ Significant difference from CCl4, P < 0.05. 
Hepatic morphological changes supported the biochemical findings reported above. A photo- 
micrograph of normal liver is shown in Fig. 1, section 1. The classical effects of CC14 are shown in 
Fig. 1, section 2. Cells have been disrupted and necrotic cellular debris can be seen in the area sur- 
rounding the central vein. Lipid accumulation is represented by the fat vacuoles in cells around the 
central vein. Small fat droplets, indicative of lipid accumulation, are seen in cells which extend 
peripherally almost as far as the portal triad. Normal cells are observed only in the area of the portal 
triad. The protective effects of nicotinamide are seen in Fig. 1, section 3. In this typical section of rat 
liver, the animal received a single dose of nicotinamide prior to the challenging dose of CC14 and two 
doses of nicotinamide after the halogenated hydrocarbon. With this treatment, the morphologica- 
picture is not strikingly different from normal rat liver (cf section 1). Even after incubation the pro- 
tective effects of the nicotinamide on the liver of the CCl4-treated animal are apparent (Fig. 1, sec. 
tion 4). 
FIG. I. (1) Liver from a normal rat (H & E, 150 I. ). (2) Liver from rat which received 2.5 ml/kg 
CC14 in peanut oil 20 hr before sacrifice (H & E, 150.~ ). (3) Liver from rat which received 
nicotinamide and 2.5 ml/kg CCL. The rat was sacrificed 20 hr after the administration of CC14 
(H & E. 150 ). (4) Liver from rat which received nicotinamide and CCIJ. The normal tem- 
perature was maintained by placing the rat in an incubator. The rat was sacrificed 20 hr after 
receiving CC% (H & E, 150 .’ ). 
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Thus it is evident from these data that the protection afforded by nicotinamide against CC14 
damage is not dependent on the fall in body temperature that is normally seen after nicotinamide 
and CC14 administration. In the present studies nicotinamide given to rats in large doses prior to 
CC14 afforded a dramatic protection. This protection by nicotinamide was reflected in the levels of 
pyridine nucleotides both in the whole liver and in the rnitochondria as well as in the histological 
studies. These data compare favorably with those of Gallagher et &,4-S who reported that other 
precursors of pyridine nucleotides (nicotinic acid and tryptophan)cgrotected rats to a considerable 
extent against the lethal effects of large doses of CC14. 
The concurrent administration of CC14 and nicotinamide caused a marked hypothermia, but neither 
nicotinamide nor CC14 alone caused any change in normal body temperature. It is especially note- 
worthy that an increase in the environmental temperature in animals given nicotinamide alone, 
caused a dramatic fall in pyridine nucleotides. 
The recent observations reported by Slater et al.12 are pertinent to the role of pyridine nucleotides 
in the liver damage caused by CCl4. These workers found that there was no significant change in the 
concentration of oxidized pyridine nucleotides at l/2, 1, 2, 3, 5, and 18 hr after CC14. They found, 
however, that NADPH was significantly decreased 30 min after CC14 administration. Preliminary 
observations in our laboratory support these data of Slater et al. They concluded that NADP and 
NADPH concentrations are related to the necrogenic chain of events that occur after CC14 admini- 
stration. More recent reports by Slater et al. 13 have revealed that promethazine, cetyltrimethyl- 
ammonium bromide, and nupercaine, which substantially delay the appearance of centrilobular 
necrosis, also minimized the loss of liver pyridine nucleotides that normally occurs 1 hr after ad- 
ministration of CC14. Preliminary data in our laboratory have shown that promethazine was less 
effective as a protective agent if the body temperature of the rat was maintained, indicating that at 
least a fraction of the protection afforded results from a change in body temperature. Slater et ~1.1~ 
also observed that phenobarbitone and cysteamine had no significant effect on the development of 
necrosis, yet prevented nucleotide decrease. It would appear, from our observations and those of 
Larson and Plaa,a that all protective agents should be screened for a hypothermic effect, with or 
without the necrogenic agent. 
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